Intelligent Antibody Discovery

News

Abeome to Present New Data on IL-25 Asthma Program at Keystone Asthma: From Pathway Biology to Precision Therapeutics

Athens, Georgia, February 3, 2017 – Abeome Corporation will present 2 posters at Keystone February 13-16, 2017 describing significant advancements in its IL-25 asthma program.

For more information see:

Keystone_IL25_Abeome_3026

and:

Keystone_IL25_Abeome_1005